The Role of Noxa/MCL-1 in Head and Neck Squamous Cell Carcinoma (HNSCC) Treatment
Head and neck cancer is the sixth leading type of cancer with 90 percent of head and neck cancer arising from squamous cell lining on the epithelium of the oral and nasal cavity, pharynx, and salivary gland. Even with tremendous achievements on chemotherapeutic drugs and therapies, the long-term pro...
Main Author: | Lee, June Young |
---|---|
Format: | Others |
Published: |
VCU Scholars Compass
2015
|
Subjects: | |
Online Access: | http://scholarscompass.vcu.edu/etd/3748 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=4797&context=etd |
Similar Items
-
Tumor-Specific Cell Death Induction by Noxa Overexpression for Head and Neck Squamous Cell Carcinoma (HNSCC) Treatment
by: Maxim, Nicolas T, Mr.
Published: (2016) -
Genetic variants of <it>NOXA</it> and <it>MCL1</it> modify the risk of HPV16-associated squamous cell carcinoma of the head and neck
by: Zhou Ziyuan, et al.
Published: (2012-05-01) -
Noxa/Mcl-1 Balance Regulates Susceptibility of Cells to Camptothecin-Induced Apoptosis
by: Yide Mei, et al.
Published: (2007-10-01) -
p53‐independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells
by: Kanika Sharma, et al.
Published: (2018-06-01) -
Combining Noxa-Inducing Drugs with ABT-263 to Efficiently Increase Cell Death in Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Kim, Sung Woo
Published: (2017)